GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Totally PLC (LSE:TLY) » Definitions » Research & Development

Totally (LSE:TLY) Research & Development : £0.0 Mil (TTM As of Sep. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Totally Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Totally's Research & Development for the six months ended in Sep. 2023 was £0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2023 was £0.0 Mil.

Totally Research & Development Historical Data

The historical data trend for Totally's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Totally Research & Development Chart

Totally Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Mar19 Mar20 Mar21 Mar22 Mar23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Totally Semi-Annual Data
Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Totally Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Totally  (LSE:TLY) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Totally Research & Development Related Terms

Thank you for viewing the detailed overview of Totally's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Totally (LSE:TLY) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Totally PLC (LSE:TLY) » Definitions » Research & Development
Comparable Companies
LSE:KNB AQSE:OHGR HCA SAU:4013 XTER:FRE SZSE:300015 THC BSP:RDOR3 BKK:BDMS XTER:FME DVA UHS XKLS:5225 ADX:PUREHEALTH HKSE:06618 NSE:APOLLOHOSP BOM:543220 EHC CHE ASX:RHC
Traded in Other Exchanges
N/A
Address
10 Nottingham Road, Cardinal Square West, Derby, GBR, DE1 3QT
Website
https://www.totallyplc.com
Totally PLC is engaged in the provision of solutions to the healthcare sector. The company's operating segment includes Urgent Care, Elective Care, Corporate Wellbeing, and Other. It generates maximum revenue from the Urgent care segment. Geographically, it operates only in the UK.

Totally (LSE:TLY) Headlines

No Headlines